Deutsche Bank’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Sell |
279,251
-561
| -0.2% | -$3.86K | ﹤0.01% | 1724 |
|
|
2025
Q1 | $806K | Sell |
279,812
-5,679
| -2% | -$16.4K | ﹤0.01% | 2233 |
|
|
2024
Q4 | $1.34M | Sell |
285,491
-424
| -0.1% | -$1.99K | ﹤0.01% | 2060 |
|
|
2024
Q3 | $1.02M | Sell |
285,915
-563,278
| -66% | -$2.01M | ﹤0.01% | 2068 |
|
|
2024
Q2 | $5.26M | Buy |
849,193
+26,095
| +3% | +$162K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $7.77M | Hold |
823,098
| – | – | ﹤0.01% | 1101 |
|
|
2023
Q4 | $5.56M | Buy |
+823,098
| New | +$5.56M | ﹤0.01% | 1205 |
|
|
2023
Q2 | – | Sell |
-31,733
| Closed | -$90.4K | – | 3768 |
|
|
2023
Q1 | $90.4K | Buy |
31,733
+12,965
| +69% | +$37K | ﹤0.01% | 3365 |
|
|
2022
Q4 | $137K | Sell |
18,768
-4,962
| -21% | -$36.1K | ﹤0.01% | 3166 |
|
|
2022
Q3 | $192K | Buy |
23,730
+2,280
| +11% | +$18.4K | ﹤0.01% | 2950 |
|
|
2022
Q2 | $105K | Sell |
21,450
-3,849
| -15% | -$18.8K | ﹤0.01% | 3473 |
|
|
2022
Q1 | $598K | Sell |
25,299
-2,088
| -8% | -$49.4K | ﹤0.01% | 2628 |
|
|
2021
Q4 | $484K | Sell |
27,387
-9,208
| -25% | -$163K | ﹤0.01% | 2860 |
|
|
2021
Q3 | $1.03M | Buy |
36,595
+23,445
| +178% | +$661K | ﹤0.01% | 2575 |
|
|
2021
Q2 | $138K | Buy |
13,150
+3,203
| +32% | +$33.6K | ﹤0.01% | 3929 |
|
|
2021
Q1 | $117K | Sell |
9,947
-891
| -8% | -$10.5K | ﹤0.01% | 3836 |
|
|
2020
Q4 | $127K | Buy |
10,838
+3,011
| +38% | +$35.3K | ﹤0.01% | 3643 |
|
|
2020
Q3 | $62K | Buy |
7,827
+1,417
| +22% | +$11.2K | ﹤0.01% | 3709 |
|
|
2020
Q2 | $117K | Buy |
6,410
+1,774
| +38% | +$32.4K | ﹤0.01% | 3322 |
|
|
2020
Q1 | $56K | Buy |
4,636
+3,126
| +207% | +$37.8K | ﹤0.01% | 3421 |
|
|
2019
Q4 | $25K | Buy |
1,510
+309
| +26% | +$5.12K | ﹤0.01% | 4075 |
|
|
2019
Q3 | $7K | Buy |
+1,201
| New | +$7K | ﹤0.01% | 4334 |
|